V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10333047 | 10039820 | 1.79 | 94.4 | Adjuvant (A) | 2022-03-25 | 2022-03-25 | R GCVP | 02 | null | BUSULFAN | 100630899 |
| 10333067 | 10039821 | 1.57 | 64.7 | Palliative (P) | 2021-04-22 | 2021-04-22 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100654888 |
| 10333215 | 10039823 | 1.69 | 60.6 | 03 | 2019-07-21 | 2019-08-01 | Acalabrutinib | 02 | null | ACALABRUTINIB | 100745175 |
| 10333268 | 10039824 | 1.76 | 82.9 | 03 | 2019-01-23 | 2019-01-23 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101521044 |
| 10333294 | 10039825 | 1.66 | 65 | Palliative (P) | 2019-06-09 | 2019-06-09 | R GCVP | 02 | N | CISPLATIN + FLUOROURACIL | 101202653 |
| 10333337 | 10039827 | 1.79 | 93.7 | Adjuvant (A) | 2019-11-22 | 2019-11-30 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100665476 |
| 10333527 | 10039830 | 1.6 | null | Not known (9) | 2016-10-13 | 2016-10-25 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | BUSULFAN | 101531649 |
| 10333576 | 10039833 | 1.64 | 68.8 | Palliative (P) | 2018-02-10 | 2018-02-10 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101130252 |
| 10333633 | 10039834 | 1.62 | 66 | Palliative (P) | 2019-09-19 | 2019-09-26 | Acalabrutinib | N | N | ACALABRUTINIB | 100614146 |
| 10333691 | 10039836 | 1.82 | 70 | Curative (C) | 2019-02-25 | 2019-03-08 | Trial Unspecified | 02 | N | PAZOPANIB | 101372735 |
| 10333705 | 10039837 | 1.64 | 0 | Palliative (P) | 2017-10-07 | 2017-10-13 | DARATUMUMAB | 02 | N | CVP R | 100964000 |
| 10333710 | 10039838 | 1.6 | null | Palliative (P) | 2019-07-16 | 2019-08-01 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 100232428 |
| 10333788 | 10039839 | 1.55 | 86 | 03 | 2019-06-13 | 2019-07-30 | Cisplatin + Fluorouracil + RT 5day | 02 | N | POMALIDOMIDE | 101240620 |
| 10333855 | 10039840 | 0 | 76.5 | null | 2018-09-02 | 2018-10-18 | MITOMYCIN | N | null | TRIAL | 100221537 |
| 10333890 | 10039841 | 1.84 | 62.55 | null | 2022-05-07 | 2022-05-11 | R GCVP | 2 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100341205 |
| 10333897 | 10039842 | 1.71 | 99.1 | Adjuvant (A) | 2018-12-29 | 2018-12-29 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100530415 |
| 10334258 | 10039845 | 1.8 | 73.4 | Palliative (P) | 2014-12-03 | 2016-06-03 | BORTEZOMIB + THALIDOMIDE | null | N | BORTEZOMIB + THALIDOMIDE | 101022664 |
| 10334333 | 10039846 | 1.53 | 81.55 | Palliative (P) | 2016-06-27 | 2016-06-27 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101227814 |
| 10334459 | 10039847 | 1.7 | 92.5 | Palliative (P) | 2019-09-20 | 2019-09-20 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100347002 |
| 10334473 | 10039848 | 1.47 | 67.85 | Palliative (P) | 2019-09-24 | 2019-09-24 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100854860 |
| 10334484 | 10039849 | 1.7 | null | Palliative (P) | 2021-01-27 | 2021-02-02 | null | 02 | null | CISPLATIN + VINORELBINE | 100089947 |
| 10334507 | 10039850 | 1.61 | 76 | Neo-adjuvant (N) | 2018-04-17 | 2018-05-01 | Pazopanib | 02 | N | VENETOCLAX | 100200605 |
| 10334541 | 10039851 | 1.67 | 75 | Palliative (P) | 2017-01-09 | 2017-01-13 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100361361 |
| 10334592 | 10039852 | 1.76 | 105.8 | 03 | 2015-09-26 | 2015-10-27 | DABRAFENIB + TRAMETINIB | 02 | N | PAZOPANIB | 100700626 |
| 10334595 | 10039853 | 1.78 | 78 | Adjuvant (A) | 2018-03-14 | 2018-03-19 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101566698 |
| 10334684 | 10039854 | null | 0 | null | null | 2018-05-11 | Cyclophosphamide + Dex + Rituximab | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101226891 |
| 10334688 | 10039855 | 1.69 | 51.1 | Palliative (P) | 2018-09-18 | 2018-09-18 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100033659 |
| 10334707 | 10039856 | 0 | 114.8 | Palliative (P) | 2019-07-13 | 2019-07-15 | CISPLATIN + FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100747171 |
| 10334720 | 10039857 | 1.6 | 59.35 | null | 2019-01-08 | 2019-03-10 | Avelumab | 02 | null | AVELUMAB | 101330571 |
| 10334840 | 10039858 | 1.78 | 94 | Disease modification (D) | 2017-01-09 | 2017-01-21 | Sunitinib | 02 | N | MITOMYCIN | 101617369 |
| 10334906 | 10039859 | 1.7 | 77.9 | Palliative (P) | 2020-12-04 | 2020-12-04 | CHOP R - 21 days | N | N | CHOP R | 101836369 |
| 10334930 | 10039860 | 1.76 | 76.4 | Adjuvant (A) | 2022-04-12 | 2022-04-12 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101158757 |
| 10334935 | 10039861 | 1.63 | 88.8 | 03 | 2019-02-01 | 2019-02-04 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | DABRAFENIB + TRAMETINIB | 101125289 |
| 10334964 | 10039862 | 1.74 | 95 | null | 2020-08-25 | 2020-08-26 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100317435 |
| 10334986 | 10039863 | 1.31 | 68 | null | 2022-02-21 | 2022-03-13 | CHOP - 21 days | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101651037 |
| 10335041 | 10039864 | 1.47 | 74.7 | Adjuvant (A) | 2020-05-28 | 2020-06-11 | R GCVP | 02 | N | POMALIDOMIDE | 100907803 |
| 10335144 | 10039866 | 1.79 | 92 | Palliative (P) | 2019-05-13 | 2019-05-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100996182 |
| 10335315 | 10039867 | 1.69 | 88.8 | 03 | 2020-12-08 | 2020-12-08 | Venetoclax | 02 | N | DABRAFENIB + TRAMETINIB | 101458707 |
| 10335324 | 10039868 | 1.71 | 80.8 | null | 2019-03-12 | 2019-04-03 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101379460 |
| 10335355 | 10039869 | null | null | null | 2018-07-25 | 2018-08-01 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100130889 |
| 10335359 | 10039870 | 1.6 | 101 | Palliative (P) | 2018-03-29 | 2018-04-04 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100852320 |
| 10335394 | 10039872 | 1.51 | 92.4 | Curative (C) | 2019-11-22 | 2019-11-30 | Capecitabine + Cisplatin + RT | 2 | null | VENETOCLAX | 101699397 |
| 10335534 | 10039873 | null | 67 | Curative (C) | 2019-08-18 | 2019-08-25 | Pazopanib | null | N | CYTARABINE | 100066909 |
| 10335548 | 10039874 | 1.67 | 89.6 | Palliative (P) | 2020-08-26 | 2020-09-02 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100900687 |
| 10335562 | 10039875 | 1.68 | 64.7 | Adjuvant (A) | 2017-12-21 | 2018-01-05 | DARATUMUMAB | null | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101091484 |
| 10335701 | 10039877 | 1.7 | 85.3 | Palliative (P) | 2017-09-14 | 2017-10-01 | Carboplatin + Vinorelbine Oral | N | N | CARBOPLATIN + VINORELBINE | 100714838 |
| 10335705 | 10039878 | 1.63 | 84 | null | 2016-02-08 | 2016-02-08 | Acalabrutinib | 02 | null | ACALABRUTINIB | 100507697 |
| 10335736 | 10039880 | 1.57 | 80.2 | null | 2018-05-03 | 2018-05-22 | CAPECITABINE + GEMCITABINE | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101380916 |
| 10335799 | 10039882 | 1.57 | 63.8 | Adjuvant (A) | 2019-02-16 | 2019-02-16 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100110642 |
| 10335959 | 10039886 | 1.63 | 54.75 | Curative (C) | 2019-03-07 | 2019-04-08 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100344054 |